81 related articles for article (PubMed ID: 7691406)
1. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part I. Isolation, amino acid sequence, homology, and origin.
Cercek L; Cercek B
Cancer Detect Prev; 1992; 16(5-6):305-19. PubMed ID: 1473120
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part II. Immunedefense suppressive effects of the CRISPPs peptide.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):433-45. PubMed ID: 7691405
[TBL] [Abstract][Full Text] [Related]
4. Effect of the cancer recognition, immunedefense suppression, and serine protease protection peptide on DNA synthesis in rat hepatocytes and human lymphocytes.
Cercek L; Carr BI; Siaw M; Cercek B
Cancer Detect Prev; 1995; 19(2):206-9. PubMed ID: 7750108
[TBL] [Abstract][Full Text] [Related]
5. A DNA probe study on the origin of the cancer recognition, immunedefense suppression and serine protease protection peptide.
Cercek L; Siaw M; Cercek B; Cercek B
Cancer Detect Prev; 1995; 19(4):325-30. PubMed ID: 7553674
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
7. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
Sun J; Pons J; Craik CS
Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
[TBL] [Abstract][Full Text] [Related]
8. Purification and biochemical characterization of ovine alpha-1-proteinase inhibitor: mechanistic adaptations and role of Phe350 and Met356.
Gupta VK; Appu Rao AG; Gowda LR
Protein Expr Purif; 2008 Feb; 57(2):290-302. PubMed ID: 17997326
[TBL] [Abstract][Full Text] [Related]
9. A novel slow-tight binding serine protease inhibitor from eastern oyster (Crassostrea virginica) plasma inhibits perkinsin, the major extracellular protease of the oyster protozoan parasite Perkinsus marinus.
Xue QG; Waldrop GL; Schey KL; Itoh N; Ogawa M; Cooper RK; Losso JN; La Peyre JF
Comp Biochem Physiol B Biochem Mol Biol; 2006 Sep; 145(1):16-26. PubMed ID: 16872855
[TBL] [Abstract][Full Text] [Related]
10. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
[TBL] [Abstract][Full Text] [Related]
11. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
12. Engineering of a macromolecular scaffold to develop specific protease inhibitors.
Stoop AA; Craik CS
Nat Biotechnol; 2003 Sep; 21(9):1063-8. PubMed ID: 12923547
[TBL] [Abstract][Full Text] [Related]
13. German cockroach frass proteases cleave pro-matrix metalloproteinase-9.
Hughes VS; Page K
Exp Lung Res; 2007; 33(3-4):135-50. PubMed ID: 17558676
[TBL] [Abstract][Full Text] [Related]
14. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.
Wallrapp C; Hähnel S; Müller-Pillasch F; Burghardt B; Iwamura T; Ruthenbürger M; Lerch MM; Adler G; Gress TM
Cancer Res; 2000 May; 60(10):2602-6. PubMed ID: 10825129
[TBL] [Abstract][Full Text] [Related]
15. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
Duranton J; Adam C; Bieth JG
Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
[TBL] [Abstract][Full Text] [Related]
16. Lys, pro and trp are critical core amino acid residues recognized by FUM20, a monoclonal antibody against serine protease pan-fungal allergens.
Lee LH; Tam MF; Chou H; Tai HY; Shen HD
Int Arch Allergy Immunol; 2007; 143(3):194-200. PubMed ID: 17284929
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.
Takada S; Kido H; Fukutomi A; Mori T; Koike K
Oncogene; 1994 Feb; 9(2):341-8. PubMed ID: 8290248
[TBL] [Abstract][Full Text] [Related]
18. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
19. Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.
Kawai SH; Aubry N; Duceppe JS; Llinàs-Brunet M; LaPlante SR
Chem Biol Drug Des; 2009 Nov; 74(5):517-22. PubMed ID: 19780760
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of alpha-lytic protease by pro region C-terminal steric occlusion of the active site.
Sohl JL; Shiau AK; Rader SD; Wilk BJ; Agard DA
Biochemistry; 1997 Apr; 36(13):3894-902. PubMed ID: 9092819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
